News & Perspective

Oct 03, 2013

Oct 03, 2013

Flu Scan for Oct 03, 2013

H3N2v shedding in ferrets
RNA-based drug development

Sep 27, 2013

Sep 27, 2013

News Scan for Sep 27, 2013

H7N9 vaccine strain selection
Vaccine research funding
Tdap vaccine shortage

Aug 20, 2013

Aug 20, 2013

CDC funding helps states boost disease detection

The CDC today announced $75 million in grants to help states and cities respond to infectious disease threats.

Jun 11, 2013

Jun 11, 2013

Federal officials weigh H7N9 vaccine options

Intensive federal deliberations are under way on whether to stockpile a vaccine against the H7N9 flu virus that emerged this spring in China.

Apr 10, 2013

Apr 10, 2013

CDC preparedness funds take hit in proposed 2014 budget

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) takes a hit of about $270 million in the Obama administration's proposed fiscal year 2014 budget, including significant cuts to biodefense and emergency preparedness programs, officials revealed today.

Feb 20, 2013

Feb 20, 2013

Study: Full-time N95 use offers best respiratory protection

(CIDRAP News) – In a new study, Chinese hospital staffers who wore N95 respirators all the time enjoyed significantly lower rates of clinical respiratory illnesses (CRIs) than workers who wore surgical masks or used N95s only for high-risk procedures.

Feb 01, 2013

Feb 01, 2013

CDC: Pandemic vaccine prevented 1 million cases, 300 deaths

(CIDRAP News) – The influenza vaccine that was developed to fight the 2009 pandemic saved roughly 300 lives and prevented about 1 million illnesses and 6,000 hospitalizations, or under 3% of the estimated total burden in each category, according to new estimates from the Centers for Disease Control and Prevention (CDC).

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Pages

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get news & practices.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M United Health Foundation Gilead Become an underwriter»